معرفی
Assoc. Prof. Paul Leonard is an Associate Professor in Biotherapeutics at Dublin City University (DCU), leading the Biomedical Innovation Group (BIG) within the School of Biotechnology. His research focuses on biomolecular interaction analysis, single-cell technologies, and biologics discovery, addressing challenges in oncology, cardiovascular disease, and infectious disease diagnostics. He has 20+ years of academic and industry experience, co-founding Remedy Biologics Ltd and securing over €15M in funding. His entrepreneurial roles include CSO/CTO, Lean Six Sigma process improvements, and advisory work for life sciences companies.
Research interests span high-throughput antibody discovery, immunoassay development, and environmental sensing. He collaborates with academia and industry, including projects like AquaBioSens for aquatic pollutant detection. His lab employs multidisciplinary teams and holds patents in biotechnology. Paul also serves as an external examiner for Technical University Dublin’s Biomedical Diagnostics program.
Key achievements include technology spin-outs, patent filings, and leadership in EU-funded projects. His work bridges academic innovation with commercial applications, emphasizing rapid diagnostic tools and therapeutic advancements.
